Exploring The Common Molecular Mechanisms Of COVID-19 And Neurodegenerative Diseases Through Bioinformatics Analysi

The COVID-19 pandemic has caused nearly seven million of deaths and remains a major public health burden worldwide.Previous studies found that a large number of COVID-19 patients and survivors developed neurological symptoms and might be at high risk of neurodegenerative diseases,such as Alzheimer’s disease(AD)and Parkinson’s disease(PD).We aimed to explore the shared pathways between COVID-19,AD,and PD by using bioinformatic analysis to reveal potential mechanisms,which may explain the neurological symptoms and degeneration of brain that occur in COVID-19 patients,and to provide early intervention.In this study,gene expression datasets of the frontal cortex were employed to detect common differentially expressed genes(DEGs)of COVID-19,AD,and PD.A total of 52 common DEGs were then examined using functional annotation,protein-protein interaction(PPI)construction,candidate drug identification,and regulatory network analysis.We found that the involvement of the synaptic vesicle cycle and down-regulation of synapses and synaptic components were shared by these three diseases,suggesting that synaptic dysfunction might contribute to the onset and progress of neurodegenerative diseases caused by COVID-19.Five hub genes and one key module were obtained from the PPI network.Moreover,5 drugs and 10 transcription factors(TFs)were also identified on the datasets.In conclusion,the results of our study provide new insights and clues for follow-up studies of the relationship between COVID-19 and neurodegenerative diseases.The hub genes and potential drugs we identified may provide promising treatment strategies to prevent COVID-19 patients from developing these disorders.